Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Growth Opportunities in Single Cell Genomics and Proteomics in the United States

Healthcare Growth Opportunities in Single Cell Genomics and Proteomics in the United States Updated Research Available

Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis

INDUSTRY
Healthcare

RELEASE DATE
08-Dec-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K998-01-00-00-00
SKU
HC_2023_402
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC_2023_402

Growth Opportunities in Single Cell Genomics and Proteomics in the United States
Published on: 08-Dec-2023 | SKU: HC_2023_402

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Request Sample
Add to Compare
Need more details?
Description

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.

Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market’s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.

This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the US Single-cell Genomics and Proteomics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Key Competitors by Workflow

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast by Workflow

Percent Revenue Forecast by Workflow

Forecast Analysis by Workflow

Revenue Forecast by Application

Percent Revenue Forecast by Application

Forecast Analysis by Application

Revenue Forecast by Technology

Percent Revenue Forecast by Technology

Forecast Analysis by Technology

Forecast Analysis by Technology (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Key Companies to Watch

Key Companies to Watch (continued)

Company Solutions

Key Technologies and Workflow—Competitor Landscape

Interest in Single-cell Genomics

Single-cell Analysis Workflow Technology

Single-cell Analysis Workflow Technology (continued)

Single-cell Analysis Workflow Technology (continued)

Key Partnerships and Collaborations

Early-stage Company Funding Trends for Single-cell Analysis

Early-stage Company Funding Trends for Single-cell Analysis (continued)

Research Center Funding Trends for Single-cell Analysis

Single-cell Genomics and Proteomics Cores around the World

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data (continued)

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes (continued)

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures & Charts
List of Figures
  • Single-cell Genomics and Proteomics: Growth Metrics, US, 2023
  • Single-cell Genomics and Proteomics: Growth Drivers, US, 2023–2028
  • Single-cell Genomics and Proteomics: Growth Restraints, US, 2023–2028
  • Single-cell Genomics and Proteomics: Revenue Forecast, US, 2023–2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Workflow, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Workflow, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Application, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Application, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Technology, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Technology, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Share by Tier Classification, Global, 2023
  • Single-cell Genomics and Proteomics: Competitive Mapping of Important Players’ Capabilities, US, 2023
  • Single-cell Genomics and Proteomics Market: Competitor Landscape, US, 2023
  • Single-cell Genomics and Proteomics Market: Publication Count, Global, 2018–2022
  • Single-cell Genomics and Proteomics Market: Partnership Assessment, US, 2023
  • Single-cell Genomics and Proteomics Market: Early-stage Company Funding for Single Cell Projects, US, 2019–2022
  • Single-cell Genomics and Proteomics Market: Research Center Funding Trends, US, 2019–2022
Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

25 Aug 2026   |   Global   |   Technology Research

Breakthrough Innovations in Point-of-Care Diagnostics

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.

The study assesses key technology shifts, including rapid molecular t...

25 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Digital Biomarkers

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications.

These biomarkers provide continuous, real-time insights into an ...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Global Single Cell Genomics and Proteomics Market, Forecast to 2023
    Release Date: 3-Sep-19
  2. Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
    Release Date: 05-May-26
  3. Proteomics Research Tools and Diagnostics Market, Global, 2024-2030
    Release Date: 14-Feb-25
  4. Recent Advances in Biomarker Technologies, Radiopharmaceuticals and Biologics
    Release Date: 22-Aug-25
  5. Innovations in Global Multiomics Technologies for Cancer
    Release Date: 17-Sep-25

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data. This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.
More Information
Deliverable Type Market Research
Author Lucila Martin
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Proteomics Industry Trends
Keyword 2 Single-Cell Genomics Market
Keyword 3 Single-Cell Proteomics
List of Charts and Figures Single-cell Genomics and Proteomics: Growth Metrics, US, 2023~ Single-cell Genomics and Proteomics: Growth Drivers, US, 2023–2028~ Single-cell Genomics and Proteomics: Growth Restraints, US, 2023–2028~ Single-cell Genomics and Proteomics: Revenue Forecast, US, 2023–2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Workflow, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Workflow, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Application, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Application, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Technology, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Technology, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Share by Tier Classification, Global, 2023~ Single-cell Genomics and Proteomics: Competitive Mapping of Important Players’ Capabilities, US, 2023~ Single-cell Genomics and Proteomics Market: Competitor Landscape, US, 2023~ Single-cell Genomics and Proteomics Market: Publication Count, Global, 2018–2022~ Single-cell Genomics and Proteomics Market: Partnership Assessment, US, 2023~ Single-cell Genomics and Proteomics Market: Early-stage Company Funding for Single Cell Projects, US, 2019–2022~ Single-cell Genomics and Proteomics Market: Research Center Funding Trends, US, 2019–2022~
Podcast No
WIP Number K998-01-00-00-00